The predictive value of multi-targeted fluorescent in-situ hybridization in patients with history of bladder cancer.

Abstract

OBJECTIVES UroVysion (Abbott Molecular Inc., Des Plaines, IL) is a multi-target fluorescent in-situ hybridization (FISH) assay that detects aneuploidy of chromosomes 3, 7, and 17, and loss of the 9p21 locus in exfoliated cells in urine. In this study, we evaluated if UroVysion can predict tumor recurrence in patients with negative cystoscopy and urinary… (More)
DOI: 10.1016/j.urolonc.2007.02.011

Topics

  • Presentations referencing similar topics